MedTrace Logo

CPX in Paradoxical Low Flow Aortic Stenosis

NCT05481814 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2022-08-01

No results posted yet for this study

Summary

Severe aortic stenosis is a condition with poor life expectancy once it becomes symptomatic. There are no prospective studies illustrating the utility of cardiopulmonary stress (CPX) testing in diagnosing and prognosticating patients with paradoxically low gradient and low flow severe aortic stenosis. We aim to prospectively investigate the utility of CPX in this patient population with the hypothesis that utilizing CPX parameters would better identify higher risk patients warranting further evaluation and possibly intervention sooner.

Conditions

  • Aortic Valve Stenosis

Sponsors & Collaborators

  • Henry Ford Health System

    lead OTHER

Principal Investigators

  • Karthikeyan Ananthasubramaniam, MD · Henry Ford Hospital

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-09-30
Primary Completion
2018-04-01
Completion
2022-07-01

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05481814 on ClinicalTrials.gov